Best Newsletters for Researchers in 2026, Sorted by What You Need

Nature Briefing (Springer Nature) is the default for a reason. It is free, it arrives every weekday, and Nature's editors pick and summarise the day's science news, opinion and analysis from Nature and other outlets. It is best for any researcher who wants one daily read outside their own field. Springer Nature also runs weekly spin-offs, including one on AI and robotics.

ScienceAdviser (Science, AAAS) is the weekday alternative from the other big general journal, drawing on news, research and commentary across the Science family of journals. Pick one of the two; reading both mostly doubles the same stories.

The Scientist Daily (LabX Media Group) is free on weekdays and leans toward life-science news and features. It suits bench biologists who want something closer to the lab than Nature or Science.

STAT runs several newsletters, and the free ones are strong. Morning Rounds and The Readout (biotech) come every weekday. D.C. Diagnosis covers US federal health agencies on Tuesdays and Thursdays, and Cancer Briefing comes on Tuesdays and Fridays. Some editions, including AI Prognosis, are for paying STAT+ subscribers only, and free readers get shortened versions of those. Start with Morning Rounds, and add D.C. Diagnosis if NIH or FDA policy affects your work.

Ground Truths (Eric Topol) covers biomedical research and medicine, roughly weekly, free with an optional paid tier. It is useful for clinical researchers who want new trials and preprints explained by a physician-scientist.

Your Local Epidemiologist (Katelyn Jetelina) translates public-health science several times a week. Most posts are free. It fits public-health researchers, and anyone who has to explain health data to non-scientists.

The Transmitter is editorially independent and funded by the Simons Foundation. It sends a daily edition on weekdays, a weekly edition on Saturdays, Spectrum on autism research on Sundays, and Launch, a monthly newsletter for early-career neuroscientists. It also runs a free neuroscience funding finder. If you work anywhere near neuroscience, this is the one to take.

Endpoints News covers the biopharma industry daily. Free registration gets you most of its newsletters, but article reading is limited without the paid Insider plan. It suits scientists who work with, or are moving toward, industry.

For biology plus technology, three independents stand out:

• Decoding Bio sends a free weekly digest of papers and funding rounds where biology meets technology.
• Asimov Press publishes long-form writing on biotechnology, free, about twice a week lately.
• Where Tech Meets Bio (BiopharmaTrend) covers AI in drug discovery each week.

The Century of Biology (Elliot Hershberg) is excellent but slow, with one long post every two to three months. Subscribe for depth, not for news.

Journalology (James Butcher, formerly at The Lancet and the Nature journals) is the best single read on scholarly publishing: journal launches, publisher deals and peer review. Be aware that most recent posts are for paid subscribers only.

Retraction Watch reports on retractions and research misconduct on weekdays, with a Weekend Reads round-up on Saturdays. Its sign-up form shows no price.

Experimental History (Adam Mastroianni) publishes essays on how science works and how it could work better, about every two weeks, free with an optional paid tier. It is the one on this list most likely to change how you think about your own field.

Manusights Weekly (ours) is a free Monday email on what changed for researchers that week: funding calls and success rates, journal and AI rules (from data sharing to figure policies), careers and pay. Each item ends with what to do about it, and every number links its source. It is written for authors rather than for the publishing industry, biomedicine first. Each issue also points to our manuscript check for anyone about to submit. See the latest issue and subscribe.

Funding calls are easy to miss, and no single free newsletter covers them across funders. Subscribe at the source:

• NIH Guide weekly table of contents (NIH) lists new funding opportunities and notices every week, usually on Friday afternoon. It is free, and essential for NIH applicants.
• NIH Extramural Nexus (NIH Office of Extramural Research) explains grants policy changes in plain language, with an email sign-up on its news page.
• FASEB Washington Update (Federation of American Societies for Experimental Biology) follows biomedical science policy and NIH in Washington, roughly every two weeks.
• FYI (American Institute of Physics) covers US science policy, physics-leaning: FYI This Week on Mondays plus a bulletin several times a week.
• Grant Witness (Raft Foundation) tracks cancelled and frozen US federal research grants, including NIH.

Outside the US, the most reliable route is still the funder's own news page or mailing list, such as the European Research Council's or Wellcome's.

Whatever you read, check every reference and claim an AI tool gives you against the original paper before it goes into your own work.

One Useful Thing (Ethan Mollick) is the most practical place to start: a research-based look at what AI tools can actually do for work and teaching, every two to four weeks, free with an optional paid tier.

If you want more depth, take one of these:

• Import AI (Jack Clark) sends a weekly read on frontier AI research.
• Ahead of AI (Sebastian Raschka) covers technical machine learning and large language models; some posts are paid-only.
• Owl Posting (Abhishaike Mahajan) is the pick for machine learning in biology, about monthly.

A stack that fits in five minutes a day for most biomedical researchers:

• Daily: Nature Briefing or ScienceAdviser, not both.
• Field: STAT Morning Rounds or The Transmitter.
• Weekly: the NIH Guide table of contents, if you apply to NIH, and one publishing or policy digest.
• Occasional: one long-read essay newsletter, such as Experimental History or The Century of Biology.

Put these in their own email folder or filter, away from collaborators' emails, and read them in one sitting at the same time each day.

What you need to keep up with changes as your job changes:

In practice, the items that change an author's next step rarely start in a general science daily. They start on a funder's or publisher's own page, and the specialist newsletters pick them up days later. We see this pattern every week in the sweep behind our Monday issue. Two recent examples:

• The European Research Council posted its 2027 Starting Grant application numbers on its own news page on October 23, 2026. Nature's analysis of what they mean for success rates followed on October 28.
• Springer Nature announced on October 26, 2026, in its own press release, that it is testing an AI assistant for peer reviewers with Google DeepMind. The release is where the details live: the tool is a prototype, no journals or start date were named, and content used to build it stays inside the publisher's private platform. A one-line news summary loses all of that, and those details are what tell you whether your next paper, data or code will be read with AI help.

The lesson for your reading stack: keep one newsletter that links its primary sources, and follow those links before you act on anything that affects a submission or an application.

Think twice before subscribing to more. The most common failure is not missing a newsletter. It is subscribing to twelve and reading none.

The duplicate daily. Two general science dailies mostly repeat each other. Keep the one you open.

The paid teaser. Some newsletters send a free summary of a paid post. Unsubscribe unless you plan to pay.

The quiet archive. If a newsletter has gone unread for three weeks, unsubscribe.

Sources accessed November 2, 2026.

1. Nature Briefing sign-up, Springer Nature.
2. ScienceAdviser, Science (AAAS).
3. The Scientist Daily sign-up, LabX Media Group.
4. STAT newsletters, STAT.
5. Ground Truths, Eric Topol.
6. Your Local Epidemiologist, Katelyn Jetelina.
7. The Transmitter newsletters and about, The Transmitter.
8. Endpoints News FAQ, Endpoints News.
9. Decoding Bio, Asimov Press, Where Tech Meets Bio and The Century of Biology.
10. Journalology, James Butcher.
11. Retraction Watch newsletter, Center for Scientific Integrity.
12. Experimental History, Adam Mastroianni.
13. NIH Guide subscription and NIH Extramural Nexus, National Institutes of Health.
14. FASEB Washington Update, FASEB.
15. FYI, American Institute of Physics.
16. Grant Witness, Raft Foundation.
17. Starting Grants 2027 applications: Facts and figures, European Research Council, October 23, 2026.
18. Is research funding now a lottery? Elite funder ERC swamped by applications, Nature, October 28, 2026.
19. Springer Nature and Google DeepMind collaborate to enhance the peer review experience, Springer Nature, October 26, 2026.
20. One Useful Thing, Import AI, Ahead of AI and Owl Posting.